PCSA

Processa Pharmaceuticals, Inc.

Healthcare · Biotechnology

$124.68 sample

-0.12 (-0.10%) 1D

Market cap

$312.3B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-04

Alerts

8

Price$124.68 -4.68% 3M daily closessample

132.96120.66

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider buy: General Counsel
Sep 18INSInsider buy: 10% owner
Sep 09INSInsider sell: Director
Sep 04SECForm 144 filed
Sep 01INSInsider sell: General Counsel
Aug 27INSInsider sell: Director
Aug 19INSInsider buy: EVP, Operations
Aug 14INSInsider sell: General Counsel

Sign up to see the real PCSA record →

Company facts

SEC EDGAR registration

Name: Processa Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -4sample, -100 to +100
Reporting currency: USD

Who is positioning in PCSA

sample

Insiders: 10 insider transactions over 90 days, net selling, $851.0M
Congress: 2 members traded over 90 days
Institutions · 13F: 35 funds hold $1.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$17.0B +16.9% y/y

Q4 2024Q3 2026

Inventory$10.0B +12.8% y/y

Q4 2024Q3 2026

Accounts receivable$8.0B +20.2% y/y

Q4 2024Q3 2026

Total debt$21.6B +13.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $81.4B +12.1% 3M
Sample peer B: $195.4B +15.8% 3M
Sample peer C: $60.7B +1.2% 3M
Sample peer D: $72.7B -6.9% 3M
Sample peer E: $70.3B +10.7% 3M